Publications by authors named "I Belaroussi"
The objective of this review is to evaluate the optimal positioning of cytoreduction surgery and perioperative medical treatments in the initial management and relapse of advanced-stage epithelial ovarian carcinoma. In the initial management, primary surgery should be proposed if the absence of tumor residue is feasible with reasonable surgery (extensive surgical resections to be considered and their complications, but also the general condition of the patient). Guidelines recommend 3 to 4 cycles of neoadjuvant chemotherapy before interval surgery for patients not eligible for primary surgery.
View Article and Find Full Text PDFArticle Synopsis
- The study examines the outcomes of three management strategies (selective fetoscopic laser coagulation, cord coagulation, and expectant management) for monochorionic diamniotic twins with selective intrauterine growth restriction and absent or reverse end-diastolic flow in the umbilical arteries.
- Overall survival rates varied significantly among the strategies, with expectant management showing the highest survival rate and lowest intrauterine demise of the co-twin.
- Long-term neurodevelopmental outcomes for survivors were generally good, indicating that the choice of management strategy may not significantly impact long-term results in both smaller and larger twins.
The development of guidelines is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients with cancer across Europe. ESMO and ESGO jointly developed clinically relevant and evidence-based recommendations in several selected areas in order to improve the quality of care for women with ovarian cancer. The ESMO-ESGO consensus conference on ovarian cancer was held on April 12-14, 2018 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of ovarian cancer.
View Article and Find Full Text PDFThe development of guidelines recommendations is one of the core activities of the European Society for Medical Oncology (ESMO) and European Society of Gynaecologial Oncology (ESGO), as part of the mission of both societies to improve the quality of care for patients with cancer across Europe. ESMO and ESGO jointly developed clinically relevant and evidence-based recommendations in several selected areas in order to improve the quality of care for women with ovarian cancer. The ESMO-ESGO consensus conference on ovarian cancer was held on 12-14 April 2018 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of ovarian cancer.
View Article and Find Full Text PDF